# HPA Axis Study in Adults

> **NCT01408511** · PHASE2 · COMPLETED · sponsor: **Bayer** · enrollment: 23 (actual)

## Conditions studied

- Atopic Dermatitis
- Eczema

## Interventions

- **DRUG:** Mapracorat

## Key facts

- **NCT ID:** NCT01408511
- **Lead sponsor:** Bayer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-07-19
- **Primary completion:** 2011-12-15
- **Final completion:** 2011-12-21
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2023-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01408511

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01408511, "HPA Axis Study in Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01408511. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*